推荐应用
Siglecs (sialic acid binding Ig-like lectins) are I-type lectins that belong to the immunoglobulin superfamily. They are characterized by an N-terminal Ig-like V-type domain which mediates sialic acid binding, followed by a varying number of Ig-like C2-type domains. Siglecs 5-11 constitute the CD33/Siglec-3 related group, and are differentially expressed in the hematopoietic system. Within the ECD, human Siglec-10 is most closely related to Siglec-5 (42% aa sequence identity). It shares 63% aa sequence identity with mouse Siglec-G. Siglec-10 is expressed on eosinophils, neutrophils, monocytes, and B cells with some splice variants predominating in particular cell types and tissue locations. It is upregulated on eosinophils in mouse models of allergic respiratory inflammation.
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
211
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
225
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
280
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
212
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
2131
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
2028
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1241
2026-04-22
【应用方向】TNFR蛋白家族概述
1213
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1407
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
1026
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
1047
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
1149
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
936
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14733
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11334
2026-09-21





